SORCS3 Protein (Sortilin-Related VPS10 Domain Containing Receptor 3)
<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#f0f0f0;">SORCS3</th></tr>
<tr><td><b>Gene</b></td><td>[SORCS3](/genes/sorcs3)</td></tr>
<tr><td><b>UniProt ID</b></td><td>[Q9UPQ6](https://www.uniprot.org/uniprot/Q9UPQ6)</td></tr>
<tr><td><b>Molecular Weight</b></td><td>120 kDa</td></tr>
<tr><td><b>Subcellular Localization</b></td><td>Plasma membrane, endosomes</td></tr>
<tr><td><b>Protein Family</b></td><td>VPS10P domain receptor family</td></tr>
<tr><td><b>Brain Expression</b></td><td>High in [hippocampus](/brain-regions/hippocampus), [cortex](/brain-regions/cortex)</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>
Introduction
SORCS3 (Sortilin-Related VPS10 Domain Containing Receptor 3) is a neuronal transmembrane receptor that plays critical roles in synaptic function, protein trafficking, and intracellular signaling in the central nervous system. As a member of the VPS10P domain receptor family, SORCS3 shares structural and functional similarities with other sortilin-related receptors including [SORCS1](/proteins/sorcs1-protein) and [SORCS2](/proteins/sorcs2-protein), all of which have been implicated in neurodegenerative diseases [@hermey2011].
Structure
SORCS3 is a type I transmembrane receptor with several distinct structural domains:
...SORCS3 Protein (Sortilin-Related VPS10 Domain Containing Receptor 3)
<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#f0f0f0;">SORCS3</th></tr>
<tr><td><b>Gene</b></td><td>[SORCS3](/genes/sorcs3)</td></tr>
<tr><td><b>UniProt ID</b></td><td>[Q9UPQ6](https://www.uniprot.org/uniprot/Q9UPQ6)</td></tr>
<tr><td><b>Molecular Weight</b></td><td>120 kDa</td></tr>
<tr><td><b>Subcellular Localization</b></td><td>Plasma membrane, endosomes</td></tr>
<tr><td><b>Protein Family</b></td><td>VPS10P domain receptor family</td></tr>
<tr><td><b>Brain Expression</b></td><td>High in [hippocampus](/brain-regions/hippocampus), [cortex](/brain-regions/cortex)</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>
Introduction
SORCS3 (Sortilin-Related VPS10 Domain Containing Receptor 3) is a neuronal transmembrane receptor that plays critical roles in synaptic function, protein trafficking, and intracellular signaling in the central nervous system. As a member of the VPS10P domain receptor family, SORCS3 shares structural and functional similarities with other sortilin-related receptors including [SORCS1](/proteins/sorcs1-protein) and [SORCS2](/proteins/sorcs2-protein), all of which have been implicated in neurodegenerative diseases [@hermey2011].
Structure
SORCS3 is a type I transmembrane receptor with several distinct structural domains:
- VPS10P Domain: The large extracellular domain that serves as the ligand-binding region, homologous to the vacuolar protein sorting 10 (VPS10) domain found in sortilin family members
- PDZ-Binding Motif: At the C-terminus, enabling interaction with PDZ domain-containing proteins involved in synaptic scaffolding
- Transmembrane Domain: Single pass membrane-spanning region
- Cytoplasmic Tail: Contains sorting motifs that direct intracellular trafficking
The VPS10P domain adopts a 10-bladed beta-propeller structure that creates a large ligand-binding pocket capable of recognizing diverse cargo proteins [@yang2018].
Normal Physiological Function
Synaptic Transmission and Plasticity
SORCS3 is predominantly expressed in [neurons](/entities/neurons) of the [hippocampus](/cell-types/hippocampal-neurons) and cerebral cortex, regions critical for learning and memory. The receptor localizes to both presynaptic terminals and postsynaptic densities, where it participates in:
Synaptic Vesicle Trafficking: SORCS3 regulates the trafficking of synaptic vesicles and synaptic proteins between the soma and synaptic terminals
Receptor Trafficking: The receptor modulates surface expression of various neurotransmitter receptors including glutamate receptors
Dendritic Spine Morphogenesis: Through interactions with scaffolding proteins, SORCS3 influences the formation and maintenance of [dendritic spines](/mechanisms/dendritic-spines)Protein Sorting and Trafficking
As a sorting receptor, SORCS3 directs proteins between different cellular compartments:
- Transports cargo from the trans-Golgi network to endosomes
- Regulates protein degradation through the lysosomal pathway
- Participates in retromer-mediated recycling
Neurotrophic Signaling
SORCS3 interacts with various neurotrophic factors and their precursors, modulating neuronal survival and differentiation pathways [^3].
Role in Alzheimer's Disease
Genetic Association
Genome-wide association studies (GWAS) have identified SORCS3 variants as significant risk factors for [Alzheimer's disease](/diseases/alzheimers-disease). Multiple single nucleotide polymorphisms (SNPs) in the SORCS3 gene locus have been associated with:
- Increased AD risk in Caucasian populations
- Earlier age of disease onset
- Faster disease progression
Mechanistic Links to AD Pathogenesis
Synaptic Dysfunction
SORCS3 deficiency contributes to synaptic impairment through multiple mechanisms:
- Reduced surface expression of AMPA and NMDA receptors
- Impaired [long-term potentiation](/mechanisms/long-term-potentiation) (LTP) in hippocampal neurons
- Abnormal dendritic spine morphology
Amyloid Processing
SORCS3 influences [amyloid precursor protein (APP)](/proteins/amyloid-beta) processing and [amyloid-beta](/proteins/amyloid-beta) metabolism. Studies show that:
- SORCS3 interacts with APP and regulates its trafficking
- Altered SORCS3 expression affects Aβ production
- The receptor participates in APP clearance pathways
Tau Pathology
Evidence suggests SORCS3 may be involved in [tau](/proteins/tau) phosphorylation and aggregation:
- SORCS3 variants correlate with [tau](/proteins/tau) levels in cerebrospinal fluid
- The receptor modulates kinases involved in tau phosphorylation
Therapeutic Potential
SORCS3 represents a potential therapeutic target for AD:
- Small molecules enhancing SORCS3 function could improve synaptic plasticity
- Gene therapy approaches to restore SORCS3 expression
- Modulation of SORCS3-dependent trafficking pathways
Role in Other Neurodegenerative Diseases
Parkinson's Disease
While primarily studied in AD, SORCS3 variants have also been associated with [Parkinson's disease](/diseases/parkinsons-disease) risk, suggesting common mechanistic pathways in protein homeostasis.
Psychiatric Disorders
SORCS3 has been linked to:
- Major depressive disorder
- Bipolar disorder
- ADHD
- Schizophrenia
Interacting Partners
Key protein interactions include:
- APP: [Amyloid precursor protein](/entities/app-protein)
- BDNF: Brain-derived neurotrophic factor
- Retromer complex: VPS26, VPS35
- PDZ proteins: PSD-95, SAP97
- Glutamate receptors: NMDA, AMPA subunits
Summary
SORCS3 is a critical neuronal receptor that links synaptic function with protein trafficking pathways. Its role in AD pathogenesis makes it an important target for understanding disease mechanisms and developing therapeutic interventions. The receptor's involvement in multiple neurodegenerative and psychiatric disorders highlights its broader importance in nervous system function.
Related Pages
- SORCS3 Gene
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
- VPS10P Receptor Family
External Links
- [UniProt: Q9UPQ6](https://www.uniprot.org/uniprot/Q9UPQ6)
- [GeneCards: SORCS3](https://www.genecards.org/cgi-bin/carddisp.pl?gene=SORCS3)
References
[Unknown, Hermey G. The Vps10p-domain receptor family. Cell Mol Life Sci. 2011;68(7):1241-1256 (2011)](https://doi.org/10.1007/s00018-010-0575-4)
[Yang M, et al., SORCS3 and neurotrophin signaling in the brain. J Neurosci. 2018;38(4):825-837 (2018)](https://doi.org/10.1523/JNEUROSCI.2345-17.2017)